Found: 7
Select item for more details and to access through your institution.
Human MAIT cell cytolytic effector proteins synergize to overcome carbapenem resistance in Escherichia coli.
- Published in:
- PLoS Biology, 2020, v. 18, n. 6, p. 1, doi. 10.1371/journal.pbio.3000644
- By:
- Publication type:
- Article
Molecular mechanisms of azole resistance in Candida bloodstream isolates.
- Published in:
- 2019
- By:
- Publication type:
- journal article
In Vitro Susceptibility to Ceftazidime-Avibactam and Comparator Antimicrobial Agents of Carbapenem-Resistant Enterobacterales Isolates.
- Published in:
- Microorganisms, 2023, v. 11, n. 9, p. 2158, doi. 10.3390/microorganisms11092158
- By:
- Publication type:
- Article
Correction to: Candidemia in a major regional tertiary referral hospital – epidemiology, practice patterns and outcomes.
- Published in:
- 2018
- By:
- Publication type:
- Correction Notice
Physicochemical Stability Study of Polymyxin B in Various Infusion Solutions for Administration to Critically Ill Patients.
- Published in:
- 2016
- By:
- Publication type:
- letter
Integrated pharmacokinetic–pharmacodynamic modeling to evaluate empiric carbapenem therapy in bloodstream infections.
- Published in:
- Infection & Drug Resistance, 2018, v. 11, p. 1591, doi. 10.2147/IDR.S168191
- By:
- Publication type:
- Article
From Bench-Top to Bedside: A Prospective In Vitro Antibiotic Combination Testing (iACT) Service to Guide the Selection of Rationally Optimized Antimicrobial Combinations against Extensively Drug Resistant (XDR) Gram Negative Bacteria (GNB).
- Published in:
- PLoS ONE, 2016, v. 11, n. 7, p. 1, doi. 10.1371/journal.pone.0158740
- By:
- Publication type:
- Article